Streetbeat News

Earnings

ASX

ASE Technology Holding Co. reported its Q2 2024 financial results with GAAP EPADS of $0.11, which was in line with expectations. However, the company reported sales of $4.351 billion, missing the estimated $4.506 billion.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:51 am

UL

Unilever expects underlying sales growth of 3%-5% for 2024, driven mainly by volume. The operating margin is projected to be at least 18%, with increased brand investment. The first half saw strong gross margin progression due to volume leverage, mix, and net productivity, but this is not expected to repeat in the second half.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:44 am

UL

Unilever (NYSE:UL) reported a 16.27% increase in H1 adjusted EPS to $1.74, up from $1.50 YoY. Sales also rose by 1.79% to $33.48 billion from $32.89 billion YoY.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:42 am

AZN

AstraZeneca has raised its 2024 guidance, now expecting total revenue and core EPS to increase by a mid-teens percentage, up from the previously anticipated low double-digit to low-teens percentage. This is due to strong growth in product sales and alliance revenue.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:34 am

AZN

AstraZeneca (NASDAQ:AZN) reported Q2 adjusted EPS of $0.99, missing the $1.20 estimate, but sales of $12.98B beat the $12.75B estimate. EPS decreased by 7.91% YoY, while sales increased by 13.73% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:28 am

INDV

Indivior has updated its financial guidance for FY 2024, expecting net revenue between $1.15B and $1.215B, which is slightly below the consensus of $1.215B. The company anticipates an adjusted gross margin in the low to mid-80% range and adjusted operating income between $285M and $320M. The guidance reflects adverse market dynamics impacting SUBLOCADE NR growth, initial commercial adoption of OPVEE, and cessation of PERSERIS sales and marketing.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:17 am

STLA

Stellantis has reiterated its financial guidance for 2024, expecting a double-digit AOI margin and positive industrial free cash flow despite macroeconomic uncertainties.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:15 am

INDV

Indivior (NASDAQ:INDV) reported Q2 earnings per share of $0.44, significantly beating the analyst estimate of $0.14. The company also reported sales of $299 million, surpassing the $296.05 million estimate. Both earnings and sales showed year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 6:09 am

STLA

Stellantis (NYSE:STLA) reported a significant decline in its half-year earnings and sales. The company's EPS dropped by 31.9% to $2.54 from $3.73 YoY, and sales decreased by 14.63% to $91.53 billion from $107.21 billion YoY.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 5:58 am

SNY

Sanofi has upgraded its 2024 business EPS guidance, now expecting it to be stable at constant exchange rates (CER) instead of a slight decrease. However, the currency impact is projected to be between -5.5% to -6.5%.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 5:43 am